To hear about similar clinical trials, please enter your email below

Trial Title: The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors

NCT ID: NCT05983380

Condition: Breast Cancer Lymphedema

Conditions: Official terms:
Breast Neoplasms
Lymphedema
Breast Cancer Lymphedema

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Intervention model description: Two groups will be compared, with treatment occurring at the same time. One group will receive the experimental exercises plus the usual treatment, the comparison group will only receive the usual treatment for breast cancer-related lymphedema.

Primary purpose: Treatment

Masking: Single (Participant)

Masking description: Participants will be masked regarding whether they are assigned to the intervention or comparison group.

Intervention:

Intervention type: Other
Intervention name: Hand Mobility and Grip Strengthening Exercises
Description: Addition of hand mobility and grip strengthening exercises to the usual care for breast cancer-related lymphedema to assess changes in limb volume, quality of life, and hand function.
Arm group label: Experimental

Intervention type: Other
Intervention name: Usual Care
Description: Manual lymphatic drainage, compression, exercise, skin hygiene.
Arm group label: Comparison
Arm group label: Experimental

Summary: The purpose of this study is to determine whether the addition of simple hand mobility and grip strengthening exercises to the usual care for upper extremity lymphedema will reduce limb volume and improve the quality of life, hand dexterity, and grip strength for those experiencing breast cancer-related lymphedema. Researchers will compare those receiving the usual treatment to those receiving the usual treatment plus hand mobility and grip strengthening exercises.

Detailed description: The purpose of this study is to determine whether the addition of simple hand mobility and grip strengthening exercises to the usual care for upper extremity lymphedema will reduce limb volume and improve the quality of life, hand dexterity, and grip strength for those experiencing early, moderate, or late stage breast cancer-related lymphedema. This study is an experimental clinical trial to determine the effectiveness of hand mobility and grip exercises on limb volume, quality of life, hand dexterity, and grip strength in women with breast cancer-related lymphedema. The two independent variables are group, a between-subject factor, and time, a within subject factor. There are two levels of the independent variable of group: (1)usual care plus hand exercises and (2) usual care alone. The independent variable of time will be assessed at three timepoints: initial to 4 weeks, 4 to 8 weeks, and initial to 8 weeks of intervention. The four dependent variables are: (1) upper limb volume, (2) quality of life, (3) hand dexterity, and (4) grip strength. If a relationship (r>0.5) is found between any of the dependent variables, MANOVA will used for analysis. If no relationship is found, a 2x3 mixed ANOVA will be used to analyze each dependent variable without a significant relationship to the others. The comparison group will receive the usual physical or occupational therapy treatment, including compression bandaging, manual lymphatic drainage, shoulder and scapular muscle exercises, and education regarding skin hygiene and monitoring. The experimental group will receive the usual treatment plus additional hand mobility and grip strengthening exercises.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Biologic women age 18 years or older with a diagnosis of clinical lymphedema of one upper extremity-early (clinical), moderate, or late stage, following treatment for breast cancer within the previous 10 years. - Women concurrently receiving immunotherapy or chemotherapy are eligible for inclusion, but an additional information request may be necessary (e.g., any activity restrictions and nadir periods) to determine whether they can safely participate in the exercise activities and apply compression. Exclusion Criteria: - Prior history of paresis in either upper limb, though paresis related to nerve compression from increased lymphatic volume will be eligible for inclusion. - Current open wounds (> 0.5 inch in length or diameter) of the axilla or edematous upper limb would be excluded, though the presence of lymphorrhea without visible skin tears will be eligible for inclusion. - Previous treatment for upper limb lymphedema or a prior diagnosis of congestive heart failure or end-stage renal disease due to the impact on edematous limbs and risk of cardiac overload. - Women who cannot speak or read English or Spanish sufficiently to complete the Lymphedema Life Impact Scale or understand the consent forms, educational information, and printed exercises will be excluded.

Gender: Female

Gender based: Yes

Gender description: Biologic women due to increased prevalence of breast cancer diagnosis.

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Presbyterian Healthplex

Address:
City: Albuquerque
Zip: 87109
Country: United States

Status: Recruiting

Contact:
Last name: Elisabeth Wise, DPT
Email: EWise@phs.org

Facility:
Name: Presbyterian Southern Outpatient Rehab

Address:
City: Rio Rancho
Zip: 87124
Country: United States

Status: Recruiting

Contact:
Last name: Elisabeth Wise, DPT
Email: EWise@phs.org

Facility:
Name: Presbyterian Santa Fe Medical Center

Address:
City: Santa Fe
Zip: 87507
Country: United States

Status: Recruiting

Contact:
Last name: Elisabeth Wise, DPT
Email: EWise@phs.org

Start date: October 1, 2023

Completion date: December 30, 2024

Lead sponsor:
Agency: Texas Woman's University
Agency class: Other

Collaborator:
Agency: Presbyterian Healthcare Services
Agency class: Other

Source: Texas Woman's University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05983380

Login to your account

Did you forget your password?